title: Approach to the patient: the adult with congenital adrenal hyperplasia.
abstract: The most common form of congenital adrenal hyperplasia is steroid 21-hydroxylase deficiency (21OHD). When the nonclassical (mild) form is included, 21OHD is the most common genetic disease in human beings. With the advent of pharmaceutical preparation of glucocorticoids starting in the 1960s and newborn screening starting in the 1990s, the majority of children with 21OHD are reaching adulthood, which has yielded a cohort of patients with, in essence, a new disease. Only recently have some data emerged from cohorts of adults with 21OHD, and in some centers, experience with the management of these patients is growing. These patients suffer from poor health, infertility, characteristic tumors in the adrenal glands and gonads, and consequences of chronic glucocorticoid therapy. Their care is fragmented and inconsistent, and many stop taking their medications out of frustration. Internal medicine residents and endocrinology fellows receive little training in their care, which further discourages their seeking medical attention. Adults with 21OHD have a different physiology from patients with Addison's disease or other androgen excess states, and their needs are different than those of young children with 21OHD. Consequently, their care requires unorthodox treatment and monitoring strategies foreign to most endocrine practitioners. Our goal for this article is to review their physiology, complications, and needs in order to develop rational and effective treatment and monitoring strategies.
authors.affiliation: Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine and the Program for Disorders of Sexual Development, University of Michigan, Room 5560A, MSRBII, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109, USA. rauchus@med.umich.edu
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Auchus
authors.forename: Wiebke
authors.initials: W
authors.lastname: Arlt
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000312:Adrenal Hyperplasia, Congenital / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D000328:Adult; D000375:Aging; D005260:Female; D006801:Humans; D007246:Infertility / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D010342:Patient Acceptance of Health Care; D057285:Precision Medicine; D013255:Steroid 21-Hydroxylase / Q000235:genetics; D060305:Transition to Adult Care
chemical_list: D013255:Steroid 21-Hydroxylase